The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

Monday, January 06, 2014

Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

11:03 EST Monday, January 06, 2014

NEW YORK (Business Wire) -- Bristol-Myers Squibb Company (NYSE: BMY) will present at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2014, in San Francisco. Lamberto Andreotti, chief executive officer,will make a formal presentation about the company at 9 a.m. PST (12:00 Noon EST).

Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Bristol-Myers Squibb
Media:
Laura Hortas, 609-252-4587
laura.hortas@bms.com
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com
Ranya Dajani, 609-252-5330
Ranya.dajani@bms.com
Ryan Asay, 609-252-5020
ryan.asay@bms.com

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections